Ardent Health Partners, LLC

NYSE:ARDT

Medical - Care Facilities

Healthcare
$14.40 -1.54%

-$0.14 today

Market cap
$2.03B
Beta
0.84
P/E (TTM)
9.4
EPS (TTM)
$0.95
52W Low $7.71High $15.48

Volume 7.27M

Average 0.45M

ARDT Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Ardent Health Partners, LLCNYSE: ARDT

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation dips below year-ago levels

Q1 FY2026 stock-based compensation of $8.93M fell 3.6% year over year, behind the +216.2% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 2.0% from the prior quarter. Over 3 fiscal years it compounded at +300.6% a year.

Context

  • Stock-based compensation amounted to 0.6% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Stock-based compensation increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -3.6% toward the trailing-twelve-month pace of +216.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.93M-2.0% QoQ
Last fiscal yearDec 2025
$39.29M+118.6% YoY
LTMMar 2026
$29.29M+216.2% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.6%——
1 year+118.6%——
3-year CAGR+300.6%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
39.29M USD
Year-over-year change
+118.6%
4-year CAGR
+190.9%

Stock-Based Compensation vs competitors

How ARDT compares with its peers on the latest reported figures

  • ARDT's LTM Mar 2026 stock-based compensation of $29.29M is the 6th largest of the 11 companies compared; the peer median is $28.69M.
  • Its year-over-year change of +216.2% is the 2nd highest of 11, against a peer median of +22.9%.
  • Stock-based compensation amounts to 0.5% of revenue for ARDT, versus a peer median of 1.1%.
ARDT Competitors Peer median
Stock-Based Compensation for ARDT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LFSTLifeStance Health Group, Inc.LTM Jun 2026$69.95M -1.1%-26.4%4.4%
BKDBrookdale Senior Living Inc.LTM Sep 2026$51.51M +289.2%-6.2%1.7%
ASTHAstrana Health, Inc.LTM Mar 2026$40.69M +11.2%+33.8%1.2%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$34.64M +37.2%+2.3%1.0%
IBRXImmunityBio, Inc.LTM Sep 2026$34.15M -8.0%-2.9%18.7%
ARDTArdent Health Partners, LLCLTM Mar 2026$29.29M +216.2%+300.6%0.5%
ADUSAddus HomeCare CorporationLTM Jun 2026$23.22M +74.9%+15.6%1.6%
MDPediatrix Medical Group, Inc.LTM Sep 2026$21.28M +37.8%+3.8%1.1%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$16.97M -165.0%—0.6%
SEMSelect Medical Holdings CorporationLTM Mar 2026$12.18M -86.9%-23.8%0.2%
NHCNational HealthCare CorporationLTM Sep 2026$6.19M +34.5%+19.0%0.4%
Peer median (excluding ARDT) $28.69M+22.9%+2.3%1.1%

Competitors are the stored peer set for ARDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income244.58M265.37M128.98M299.71M230.14M
Depreciation & Amortization137.2M138.17M140.84M146.29M155.7M
Deferred Income Tax(30.65M)46.12M4M24.04M43.59M
Stock-Based Compensation549K611K904K17.98M39.29M
Change in Working Capital(89.55M)(9.74M)(56.31M)(181.75M)(3.34M)
Accounts Receivables(96.47M)(17.18M)(181.1M)40M59.16M
Inventory(5.73M)4.67M1.67M(9.41M)(3.15M)
Accounts Payables109.35M14.42M136.82M(103.86M)62.06M
Other Working Capital(96.71M)(11.65M)(13.7M)(108.49M)(121.41M)
Other Non-Cash Items(115.22M)(478.89M)3.29M8.76M5.13M
Operating Cash Flow146.91M(38.36M)221.7M315.03M470.51M
Capital Expenditures(139M)(151.11M)(137.41M)(187.51M)(211.9M)
Acquisitions (Net)(2.28M)206.37M0(31.25M)(2.5M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities5.03M(8.69M)(575K)(1.71M)179K
Investing Cash Flow(136.26M)46.58M(137.98M)(220.46M)(214.23M)
Debt Repayment(84.45M)(16.41M)(7.03M)(104.77M)(7.99M)
Common Stock Issued000208.66M0
Common Stock Repurchased00000
Dividends Paid(62.13M)(174.81M)000
Other Financing Activities(137.33M)(79.11M)(95.24M)(79.24M)(95.48M)
Financing Cash Flow(283.91M)(270.33M)(102.26M)24.64M(103.47M)
Effect of Forex Changes00000
Net Change in Cash(273.26M)(262.11M)(18.55M)119.21M152.82M
Free Cash Flow7.91M(189.47M)84.29M127.52M258.61M

Ardent Health Partners, LLC

NYSE:ARDT

Intrinsic Alpha fair value

Locked

Current Price

$14.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.